HCPCS Level IIdrugActive
J0217
Inj velmanase alfa-tycv 1 mg
BETOS: O1E
Effective: 2024-01-01
Description
Injection, velmanase alfa-tycv, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lamzede
Manufacturer
Chiesi USA, Inc.
HCPCS Dosage
1 MG
Billing Units
10.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.